DIGITAL-ELEMENT
Seeding Alliance , a leading specialist in native advertising, has seen significantly improved performance following its partnership with Digital Element , the global geolocation and audience insights provider, with click-through rates boosted by as much as 20%. Having chosen Digital Element’s NetAcuity PulseTM technology, the Cologne-based native advertising experts now offer enhanced geo-based ad serving for their clients as well as in-depth traffic analysis for fraud identification.
Based in Germany, Seeding Alliance is one of the leaders in native advertising - a core tactic to engage consumers. By placing ads that authentically match the feel and function of the media in which they reside, Seeding Alliance allows the publishing of content that effectively targets relevant audiences without disrupting the natural editorial format of the publication.
Seeding Alliance selected Digital Element’s NetAcuity Pulse IP intelligence solution in May 2019 to improve their geolocation services and gain access to global IP datasets, enabling segmentation of relevant audiences based on various information layers – such as connection type, mobile carrier and internet service provider – without the user becoming personally identifiable. This has clearly helped to ensure the success of Seeding Alliance’s clients’ advertising campaigns, as consumers can be targeted with appropriate and relevant geo-location based ads to efficiently utilise advertising budgets and minimise fraud.
“Our previous solution choices were simply too inaccurate and incomplete, which led us to the decision to move data providers and choose the market leader, Digital Element, to achieve the best possible results for our clients,” commented Adrian Meyer, VP Technology at Seeding Alliance. “Shortly after the integration of the Digital Element data we realised that we were successfully blocking more fraud attempts and that the advertising campaigns were performing better. We have always been keen to provide sustainable increase in brand awareness, across extensive formats, without compromising consumer convenience and this partnership with Digital Element means we can now effectively target more tightly defined audiences, through the use of location specific content and IP intelligence.”
Digital Element’s NetAcuity Pulse™ uses a network of IP location information derived from mobile devices, billions of on-device-location transactions, and internet routing infrastructure. This very precise – yet privacy-sensitive – global online targeting method is based on where a user is located and connected at a specific point in time, regardless of device. Information can include whether or not the connection is being made through a wifi network, the user’s point-in-time geographic location, and whether a home or business hotspot is in use. The benefits of using intelligent and precise targeting at scale include increased revenues, better return on investment, stronger brand loyalty, and improved consumer engagement.
“Seeding Alliance required a high level of accurate and intelligent support and we are delighted they chose our NetAcuity Pulse technology to assist them in tailoring their native advertising campaigns to target more specific audiences, and add to their armory for fighting ad fraud,” said Kate Owen, Digital Element’s Vice-President, Northern Europe. “We are proud of the accuracy of our data and one year on, it’s clear we have provided Seeding Alliance with valuable insights for them to continue to build on their success in this competitive advertising world.”
Seeding Alliance joins Digital Element’s portfolio of high-profile clients, which includes: Adobe, Facebook, Pinterest, LinkedIn, Taboola, Codewise, Amobee, Twitter, MediaMath, Adform, BBC, Discovery Networks, Hubspot, Vibrant Media, Webtrends, Crimtan, Weborama, Ogilvy and many others.
About Digital Element
Since 1999, Digital Element has been providing global geolocation and audience insights that bring anytime, anywhere relevance and context to online initiatives—from desktops to mobile devices. The company’s patented technology has been certified and accredited to deliver real-time access to accurate and reliable location intelligence without invading Internet users’ privacy. For over two decades, many of the world’s largest websites, brands, security companies, ad networks, social media platforms and mobile publishers have trusted Digital Element’s technology to target advertising, localize content, enhance analytics, and manage content rights as well as detect and prevent fraud.
Visit http://www.digitalelement.com for more information on how to bring the power of location to the online world. Follow us on LinkedIn and Twitter @DigitalElement then like us on Facebook .
Headquartered in Atlanta and London, Digital Element is a division of Digital Envoy Inc .
About Seeding Alliance
The Seeding Alliance GmbH is one of the leading marketers and developers of native advertising formats and the largest independent native advertising marketer in Germany. With a specially developed ad server for native forms of advertising, the Seeding Alliance is an innovative contact point for publishers and advertisers. Based in Cologne, Seeding Alliance was founded in 2011 by Coskun Tuna and Cevahir Ejder and has been part of the Ströer Group since March 2017.
Visit www.seeding-alliance.de for more information.
View source version on businesswire.com: https://www.businesswire.com/news/home/20200630005058/en/
Link:
About Business Wire
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
BeOne Medicines Granted U.S. FDA Fast Track Designation for BGB-B2033 as Treatment for Hepatocellular Carcinoma18.12.2025 12:00:00 CET | Press release
BGB-B2033 is a bispecific antibody directed at GPC3 and 4-1BB; key targets in the most common liver cancerFDA Fast Track Designation reflects the potential of BGB-B2033 in an area of high unmet need BeOne Medicines Ltd. (Nasdaq: ONC; HKEX: 06160; SSE: 688235), a global oncology company, today announced that the U.S. Food and Drug Administration (FDA) has granted the Company Fast Track Designation for BGB-B2033, its GPC3x4-1BB bispecific antibody for the treatment of adult patients with hepatocellular carcinoma (HCC) with disease progression on or after prior systemic treatment. “The FDA awards Fast Track Designation to therapies that show potential to address an unmet medical need in serious or life-threatening conditions. The FDA’s decision reflects the encouraging profile of BGB-B2033 in advanced hepatocellular carcinoma, where patients continue to face limited treatment options,” said Julie Lepin, Senior Vice President and Chief Regulatory Affairs Officer at BeOne. BeOne is currentl
NHOA Energy Achieves Great Place To Work Certification in Italy, the United States and Australia18.12.2025 10:53:00 CET | Press release
NHOA Energy, global provider of utility-scale energy storage systems, announces that it has been certified Great Place To Work® in Italy, the United States, and Australia. The certification is based entirely on direct feedback from NHOA Energy employees, gathered through an independent and structured listening process. Great Place To Work® Certification™ assesses the quality of the employee experience across key dimensions such as credibility, respect, fairness, pride, and camaraderie. The results achieved by NHOA Energy reflect a corporate culture built on trust, inclusion, and the consistent commitment to valuing people within a dynamic and international environment. Employees highlighted particularly high levels of appreciation for the ethical and transparent behavior of leaders, the welcoming and inclusive approach toward new hires, and fair treatment across diversity, equity, and inclusion dimensions. A strong majority also expressed pride in working at NHOA Energy and reported a
Regnology Signs an Agreement to Acquire Moody’s Regulatory Reporting & ALM Solutions18.12.2025 10:00:00 CET | Press release
The deal further strengthens Regnology’s global position in Regulatory Reporting and significantly accelerates its expansion into new markets Regnology, a leading provider in regulatory, risk, tax, and finance reporting, as well as supervisory technology, today announced it has signed an exclusive agreement for the acquisition of Moody’s Regulatory Reporting & ALM Solutions business, inclusive of solutions for Basel III compliance, IFRS9 impairment accounting, large bank asset-liability management (ALM), Solvency II insurance reporting, and prudential and statistical regulatory reporting across more than 50 jurisdictions. By integrating Moody’s regulatory capital and liquidity capabilities with Regnology’s regulatory, risk, and finance offerings, the firm is creating a unified, scalable platform designed to meet the full spectrum of financial regulatory compliance and risk requirements. This combined strength positions Regnology as the partner of choice for financial institutions seeki
Reply Recognized as a Microsoft Azure Expert Managed Services Provider for the Sixth Consecutive Year18.12.2025 10:00:00 CET | Press release
Reply [EXM, STAR: REY] announced today it has been recognized once again as a Microsoft Azure Expert Managed Services Provider (MSP). The renewal reaffirms Reply’s proven expertise and consistent track record in delivering high-quality cloud solutions and services on the Microsoft Azure platform, powered by the deep technical expertise of its specialized companies – Cluster Reply, Solidsoft Reply and Valorem Reply. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20251218596617/en/ This recognition reflects the ongoing collaboration between Reply - through its companies Cluster Reply, Solidsoft Reply, and Valorem Reply - and Microsoft, supporting shared efforts to deliver value-driven services to enterprise customers. The Azure Expert MSP program is designed by Microsoft to identify and validate partners with proven capabilities in delivering end-to-end Azure services at scale. To qualify, partners must meet a strict set of requ
Takeda’s Zasocitinib Landmark Phase 3 Plaque Psoriasis Data Show Promise to Deliver Clear Skin in a Once-Daily Pill, Catalyzing a New Era of Treatment18.12.2025 09:00:00 CET | Press release
Pivotal Phase 3 studies of once-daily oral zasocitinib met all primary and ranked secondary endpoints in patients with moderate-to-severe plaque psoriasis More than half of study participants treated with zasocitinib achieved clear or almost clear skin (PASI 90), and on average about 30 percent achieved completely clear skin (PASI 100) by week 16 Zasocitinib was generally well-tolerated with a safety profile consistent with previous clinical studies Takeda(TSE:4502/NYSE:TAK)today announced positive topline results for the two pivotal Phase 3randomized, multicenter, double-blind, placebo- and active comparator-controlled studies of zasocitinib (TAK-279), a next-generation, highly selective oral tyrosine kinase 2 (TYK2) inhibitor, in adults with moderate-to-severe plaque psoriasis (PsO). The studies demonstrated superiority of zasocitinib compared to placebo for the co-primary endpoints, static Physician Global Assessment (sPGA) 0/1 and Psoriasis Area and Severity Index (PASI) 75, at wee
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom